BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37949717)

  • 1. The relationship between serum creatinine/cystatin C ratio and mortality in hypertensive patients.
    Liao L; Shi S; Ding B; Zhang R; Tu J; Zhao Y; Guo Q; Liao Y
    Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):369-376. PubMed ID: 37949717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease.
    Kawasaki Y; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
    Respir Investig; 2024 Jan; 62(1):143-149. PubMed ID: 38134662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults.
    Shi S; Jiang Y; Chen W; Chen K; Liao Y; Huang K
    Front Nutr; 2022; 9():897774. PubMed ID: 36017221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer.
    Fukushima R; Harimoto N; Okuyama T; Seki T; Hoshino K; Hagiwara K; Kawai S; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Shirabe K
    Int J Clin Oncol; 2024 Jul; 29(7):1002-1011. PubMed ID: 38683456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
    Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
    BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
    Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
    BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
    Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
    Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic performance of Cr/CysC for sarcopenia and its predictive value on clinical outcomes in hospitalized older patients: a prospective cohort study.
    Tu X; Lin T; Huang L; Tang T; Xie D; Gao L; Jiang T; Yue J
    Eur Geriatr Med; 2024 Apr; 15(2):579-588. PubMed ID: 38393457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.
    Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q
    Front Nutr; 2022; 9():963265. PubMed ID: 36118766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
    Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease.
    Hyun YY; Lee KB; Kim H; Kim Y; Chung W; Park HC; Han SH; Oh YK; Park SK; Oh KH
    Front Nutr; 2022; 9():996674. PubMed ID: 36225865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia.
    Huang S; Guo Y; Chen L; Wang Y; Chen X
    BMC Geriatr; 2022 Nov; 22(1):880. PubMed ID: 36402966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer.
    Tsukagoshi M; Watanabe A; Araki K; Ishii N; Hagiwara K; Hoshino K; Muranushi R; Harimoto N; Takizawa M; Shirabe K
    Ann Gastroenterol Surg; 2023 Sep; 7(5):784-792. PubMed ID: 37663967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel equations incorporating the sarcopenia index based on serum creatinine and cystatin C to predict appendicular skeletal muscle mass in patients with nondialysis CKD.
    Hsu BG; Wang CH; Lai YH; Kuo CH; Lin YL
    Clin Nutr; 2024 Mar; 43(3):765-772. PubMed ID: 38335801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
    Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
    Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
    Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
    Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Huang D; Xie C; Sun C; Chen M; Li L; Yi H; Liao J; Zhao X; Shen X; He D; Li D; Wu D
    Int J Chron Obstruct Pulmon Dis; 2022; 17():781-789. PubMed ID: 35422619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis.
    Lin T; Jiang T; Huang X; Xu P; Liang R; Song Q; Tu X; Zhao Y; Huang L; Yue J; Wu C
    Age Ageing; 2024 Jan; 53(1):. PubMed ID: 38251741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum creatinine to cystatin C ratio is associated with low tongue pressure.
    Komorita Y; Ide H; Yoshinari M; Ohta Y; Nakamichi I; Fujisawa R; Fujii W; Fukuhara M
    Geriatr Gerontol Int; 2024 Jan; 24(1):102-108. PubMed ID: 38110724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A baseline sarcopenia index based on creatinine/cystatin C for the prediction of stroke recurrence and mortality in older survivors of first ischemic strokes.
    Hou L; Chen X; Zhu C
    Front Public Health; 2023; 11():1049738. PubMed ID: 37841730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.